Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Perlmutter

Showing results (321-330 of 568) with videos related to

Pageof 57
Sort By:
Developmental Medicine and Child Neurology|January 26, 2023
Determinants of gait dystonia severity in cerebral palsyBhooma R Aravamuthan, Toni S Pearson, Keisuke Ueda, et al.
The New England Journal of Medicine|July 28, 2021
Revisiting FDA Approval of AducanumabG Caleb Alexander, David S Knopman, Scott S Emerson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 20, 2019
The impact of dopamine D<sub>2</sub>-like agonist/antagonist on [<sup>18</sup>F]VAT PET measurement of VAChT in the brain of nonhuman primatesHui Liu, Zonghua Luo, Jiwei Gu, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 11, 2006
[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studiesBrad A Racette, Laura Good, Jo Ann Antenor, et al.
Chemmedchem|August 3, 2018
Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the BrainZonghua Luo, Hui Liu, Hongjun Jin, et al.
Biological Psychiatry|April 28, 2004
Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot studyTamara Hershey, Kevin J Black, Johanna M Hartlein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2005
[18F]FDOPA PET and clinical features in parkinsonism due to manganismBrad A Racette, Jo Ann Antenor, Lori McGee-Minnich, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 10, 2018
Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C<sub>3</sub>] in Mice and PrimatesJoshua I Hardt, Joel S Perlmutter, Christopher J Smith, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1986
Strategies for in vivo measurement of receptor binding using positron emission tomographyJ S Perlmutter, K B Larson, M E Raichle, et al.
Synapse (New York, N.Y.)|May 9, 2009
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterizationJinbin Xu, Wenhua Chu, Zhude Tu, et al.
Pageof 57

Showing results (321-330 of 568) with videos related to

Sort By:
Pageof 57
Developmental Medicine and Child Neurology|January 26, 2023
Determinants of gait dystonia severity in cerebral palsyBhooma R Aravamuthan, Toni S Pearson, Keisuke Ueda, et al.
The New England Journal of Medicine|July 28, 2021
Revisiting FDA Approval of AducanumabG Caleb Alexander, David S Knopman, Scott S Emerson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 20, 2019
The impact of dopamine D<sub>2</sub>-like agonist/antagonist on [<sup>18</sup>F]VAT PET measurement of VAChT in the brain of nonhuman primatesHui Liu, Zonghua Luo, Jiwei Gu, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 11, 2006
[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studiesBrad A Racette, Laura Good, Jo Ann Antenor, et al.
Chemmedchem|August 3, 2018
Exploration of Sulfur-Containing Analogues for Imaging Vesicular Acetylcholine Transporter in the BrainZonghua Luo, Hui Liu, Hongjun Jin, et al.
Biological Psychiatry|April 28, 2004
Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot studyTamara Hershey, Kevin J Black, Johanna M Hartlein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2005
[18F]FDOPA PET and clinical features in parkinsonism due to manganismBrad A Racette, Jo Ann Antenor, Lori McGee-Minnich, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 10, 2018
Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C<sub>3</sub>] in Mice and PrimatesJoshua I Hardt, Joel S Perlmutter, Christopher J Smith, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 1, 1986
Strategies for in vivo measurement of receptor binding using positron emission tomographyJ S Perlmutter, K B Larson, M E Raichle, et al.
Synapse (New York, N.Y.)|May 9, 2009
[(3)H]4-(Dimethylamino)-N-[4-(4-(2-methoxyphenyl)piperazin- 1-yl)butyl]benzamide, a selective radioligand for dopamine D(3) receptors. I. In vitro characterizationJinbin Xu, Wenhua Chu, Zhude Tu, et al.
Pageof 57